DOV Pharmaceutical, Inc

DOV Pharmaceutical, Inc. is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, or CNS, disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, pain and depression.DOV currently has three product candidates in various stages of clinical development by the Company, namely, bicifadine, DOV 21,947 and DOV 102,677. DOV has entered into collaborations for two additional DOV product candidates, indiplon and DOV 216,303, and is seeking a partner for a third product candidate, DOV diltiazem.

Contact Details: 150 Pierce St Somerset New Jersey 08873 United States of America Tel: 732.907.3600 Fax: 732.907.3799 Email: IR@dovpharm.com WWW: www.dovpharm.com/

Loading...

Press Releases on DOV Pharmaceutical, Inc:
Neurocrine Biosciences Reports Second Quarter 2008 Results	30th July, 2008	Neurocrine Biosciences, Inc.	SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended June 30, 2008. For the second quarter of 2008,

BioNews Results for DOV Pharmaceutical, Inc:
Dov Pharmaceutical Inc-Detailed Product Pipeline - research report released	PR inside:  Nov 3 2009 9:07AM Matching: dov pharmaceutical inc
Dov Pharmaceutical Inc-Financial Company Report - research report released	PR inside:  Oct 30 2009 8:34PM Matching: dov pharmaceutical inc

DOV Pharmaceutical, Inc Clinical Trials:
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

DOV Pharmaceutical, Inc Patents:
US Patent No.	Title
7098230	(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
7098229	(+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
7094799	Polymorphs of bicifadine hydrochloride
7081471	(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
6716868	(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
→View more DOV Pharmaceutical, Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 388 times since April 2007, the link to the organisation's website has been followed 53 times

Search for more companies in Somerset

Search for more companies in New Jersey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DOV Pharmaceutical, Inc